Refractory immune thrombocytopenia after heart transplantation: a case report.
Chronic immune thrombocytopenia responds to steroids and splenectomy in approximately 80% of the patients. Intravenous immunoglobulin, plasmapheresis, combination chemotherapy, and androgens may help in refractory cases. This report describes the course and management of refractory immune thrombocytopenia after heart transplantation.
Dhar
S C
SC
St. Louis University Health Sciences Center, Mo. 63110, USA.
Miller
L W
LW
D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D001792:Blood Platelets / Q000276:immunology; D001853:Bone Marrow / Q000473:pathology; D002908:Chronic Disease; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D006330:Heart Defects, Congenital / Q000601:surgery*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000276:immunology / Q000473:pathology / Q000628:therapy; D010951:Plasma Exchange; D010956:Plasmapheresis; D011183:Postoperative Complications / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D012008:Recurrence; D013156:Splenectomy; D013921:Thrombocytopenia / Q000276:immunology* / Q000473:pathology / Q000628:therapy
D001323:Autoantibodies; D007166:Immunosuppressive Agents